MBQ PHARMA INC.

SAN JUAN, PR · CIK 0002148840 · Biotech

mbqpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$4.2M
5 Form D · Aug 2026
2 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 5 same dayForm D · SEC$325,000
Private capital raised· 2 of 5 same dayForm D · SEC$500,000
Private capital raised· 3 of 5 same dayForm D · SEC$991,038
Private capital raised· 4 of 5 same dayForm D · SEC$1,530,000
Private capital raised· 5 of 5 same dayForm D · SEC$882,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1817Hapten Sciences, Inc.—$2.7M
1818REVIVA PHARMACEUTICALS HOLDINGS, INC.——
1819KYRON, INC.—$3.0M
1820MBQ PHARMA INC.—$4.2M
1821NEUROPATHIX, INC.—$1.3M
1822CUMBERLAND PHARMACEUTICALS, INC.——
1823Biohaven Environmental Solutions, LLC—$1.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • SURANGANIE DHARMAWARDHANEDirector · Executive Officer
  • CARLOS DOMINGUEZDirector · Executive Officer
  • ARTURO GONZALEZDirector
  • FEDERICO GOODSAIDDirector · Executive Officer
  • HUMBERTO GUZMANDirector
  • ELIUD HERNANDEZExecutive Officer
  • JOSE RODRIGUEZ-ORENGODirector · Executive Officer
  • NEIL SANKARExecutive Officer
  • CORNELIS VLAARDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.